GAMMA Investing
ZNTL icon

GAMMA Investing’s Zentalis Pharmaceuticals ZNTL Stock Holding History

GAMMA Investing’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$568 Buy
+205
New +$827 ﹤0.01% 4192
2024
Q3 		– Sell
-2
Closed -$8 – 3655
2024
Q2 		$8 Sell
2
-24
-92% -$268 ﹤0.01% 3442
2024
Q1 		$410 Buy
26
+7
+37% +$96 ﹤0.01% 3134
2023
Q4 		$225 Buy
+19
New +$277 ﹤0.01% 3111

Other funds holding ZNTL

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
EWML
Eiger Wealth Management, LLC San Diego, California $4.62M AUM 47.56% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
DLK Investment Management
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

GAMMA Investing's ZNTL Position: Q3 2026 in Review

GAMMA Investing opened a new position in Zentalis Pharmaceuticals (ZNTL) in Q3 2026: 205 shares worth $568. The stake represents ﹤0.01% of the portfolio and ranks #4192 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in ZNTL as recently as Q2 2024.

GAMMA Investing first reported a position in ZNTL in Q4 2023 and has held it in 4 quarters since. 24 funds tracked by Wall St. Rank hold ZNTL as of Q3 2026.

  • GAMMA Investing held 205 shares of Zentalis Pharmaceuticals worth $568 as of Q3 2026.
  • Zentalis Pharmaceuticals was a new GAMMA Investing position in Q3 2026.
  • Zentalis Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4192 holding.
  • GAMMA Investing first reported a position in Zentalis Pharmaceuticals in Q4 2023 and has held it in 4 quarters since.
  • 24 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.